Literature DB >> 19710

FLA 136: selective agonist at central alpha-adrenoreceptors mediating changes in the turnover of noradrenaline.

N E Andén, M Grabowska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 19710     DOI： 10.1007/BF00500894

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  15 in total

1.  AN IMPROVED METHOD FOR FLUORIMETRIC DETERMINATION OF SMALL AMOUNTS OF ADRENALINE AND NORADRENALINE IN PLASMA AND TISSUES.

Authors:  J HAEGGENDAL
Journal:  Acta Physiol Scand       Date:  1963-11

2.  The preparation and antihypertensive activity of 4-amino-3-(2,6-dichlorobenzylidenehydrazino)-1,2,4-triazole and some related compounds.

Authors:  H E Eriksson; L G Florvall
Journal:  Acta Pharm Suec       Date:  1976

3.  Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.

Authors:  N E Andén; M Grabowska; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

4.  Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.

Authors:  A Carlsson; J N Davis; W Kehr; M Lindqvist; C V Atack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

5.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

6.  Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine.

Authors:  H Schmitt; S Fénard
Journal:  Arzneimittelforschung       Date:  1973-01

7.  Central effects of an inhibitor of tyrosine hydroxylation.

Authors:  H Corrodi; L C Hanson
Journal:  Psychopharmacologia       Date:  1966

8.  Refillment of the catecholamine stores with 3,4-dihydroxyphenylalanine after depletion induced by inhibition of tyrosine-hydroxylase.

Authors:  H Corrodi; K Fuxe; T Hökfelt
Journal:  Life Sci       Date:  1966-04       Impact factor: 5.037

9.  A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain.

Authors:  W Kehr; A Carlsson; M Lindqvist
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

10.  Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain.

Authors:  N Andén; M Grabowska
Journal:  Eur J Pharmacol       Date:  1976-10       Impact factor: 4.432
View more
  5 in total

1.  Involvement of presynaptic alpha-adrenoceptors in the cardiovascular and sedative effects of FLA-136.

Authors:  P B Timmermans; E Lam; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-03       Impact factor: 3.000

2.  Proceedings of the British Pharmacological Society. 17th-19th December, 1979: University of London (Institute of Education).

Authors: 
Journal:  Br J Pharmacol       Date:  1980-06       Impact factor: 8.739

3.  Selective stimulation of central alpha-autoreceptors following treatment with alpha-methyldopa and FLA 136.

Authors:  N E Andén
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-04       Impact factor: 3.000

4.  A comparison of the cardiovascular and sedative actions of the alpha-adrenoceptor agonists, FLA-136 and clonidine, in the rat.

Authors:  T C Hamilton; S D Longman
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

5.  Is Ro 11-2465 (cyan-imipramine) an antagonist of postsynaptic serotonin receptors?

Authors:  L Pawłowski; H Kwiatek; Z Górka
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.